Home 2019
Archives
SABCS: Anastrozole Tied to Lasting Reduction in Breast Cancer Risk
Breast cancer risk significantly lower at median follow-up of 131 months; effect continued after treatment
SABCS: Breast Cancer Rates Opposite for Estrogen, Estrogen + Progestin
In postmenopausal women, breast cancer incidence down with estrogen alone, up with CEE + MPA
SABCS: Long-Term Outcomes Good for PBI in Early Breast Cancer
10-year ipsilateral breast tumor recurrence rates similar for partial, whole breast irradiation
SABCS: Addition of Tucatinib Ups Survival in HER2+ Metastatic Breast Cancer
In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression-free survival
Purified CBD May Help Treat Drug-Resistant Epilepsy
Those taking CBD versus placebo had greater reduction in seizures associated with tuberous sclerosis complex
ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma
Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT
ASH: PET Helps Tailor Therapy in Limited-Stage DLBCL
Most patients had negative PET scan and completed one additional R-CHOP cycle without radiation
RSNA: Brachytherapy Treats Skin Cancer in Elderly Patients
Brachytherapy alternative to Mohs surgery in early-stage nonmelanoma skin cancers of head, neck
RSNA: Brain Changes Observed on MRI in Obese Teens
Pattern of damage seen in regions responsible for control of appetite, emotions, cognitive functions
RSNA: Biennial Mammo Returns More Advanced-Stage Cancers
Annual mammography screening, used by most patients, yields smaller and less advanced cancers
